BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36652988)

  • 1. Expression of RANKL in breast cancer tissue in patients with fibrous dysplasia/McCune-Albright syndrome.
    Meier ME; Hagelstein-Rotman M; Majoor BCJ; Geels RES; Appelman-Dijkstra NM; Bravenboer N
    Bone; 2023 Apr; 169():116679. PubMed ID: 36652988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of RANKL, OPG, IL-6 and sclerostin as biomarkers for fibrous dysplasia/McCune-Albright syndrome.
    Meier ME; Hagelstein-Rotman M; Streefland TCM; Winter EM; Bravenboer N; Appelman-Dijkstra NM
    Bone; 2023 Jun; 171():116744. PubMed ID: 36958543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extent of Extraskeletal Manifestations of Fibrous Dysplasia/McCune-Albright Syndrome in Patients with Mazabraud's Syndrome.
    Hagelstein-Rotman M; Appelman-Dijkstra NM; Boyce AM; Chapurlat R; Dur NBJ; Gensburger D; Majoor BCJ; van de Sande MAJ; Dijkstra PDS
    Calcif Tissue Int; 2022 Mar; 110(3):334-340. PubMed ID: 34854944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia.
    Kobayashi K; Imanishi Y; Koshiyama H; Miyauchi A; Wakasa K; Kawata T; Goto H; Ohashi H; Koyano HM; Mochizuki R; Miki T; Inaba M; Nishizawa Y
    Life Sci; 2006 Apr; 78(20):2295-301. PubMed ID: 16337659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multidisciplinary care pathway improves quality of life and reduces pain in patients with fibrous dysplasia/McCune-Albright syndrome: a multicenter prospective observational study.
    Meier ME; Hagelstein-Rotman M; van de Ven AC; Van der Geest ICM; Donker O; Pichardo SEC; Hissink Muller PCE; van der Meeren SW; Dorleijn DMJ; Winter EM; van de Sande MAJ; Appelman-Dijkstra NM
    Orphanet J Rare Dis; 2022 Dec; 17(1):439. PubMed ID: 36528764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Prevalence of Malignancies in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS): Data from a National Referral Center and the Dutch National Pathology Registry (PALGA).
    Hagelstein-Rotman M; Meier ME; Majoor BCJ; Cleven AHG; Dijkstra PDS; Hamdy NAT; van de Sande MAJ; Dekkers OM; Appelman-Dijkstra NM
    Calcif Tissue Int; 2021 Mar; 108(3):346-353. PubMed ID: 33226445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of GNAS Variants in Circulating Cell-Free DNA from Patients with Fibrous Dysplasia/McCune Albright Syndrome.
    Roszko KL; Guthrie L; Li X; Collins MT; de Castro LF; Boyce AM
    J Bone Miner Res; 2023 Mar; 38(3):443-450. PubMed ID: 36593655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated With Disease Burden.
    de Castro LF; Burke AB; Wang HD; Tsai J; Florenzano P; Pan KS; Bhattacharyya N; Boyce AM; Gafni RI; Molinolo AA; Robey PG; Collins MT
    J Bone Miner Res; 2019 Feb; 34(2):290-294. PubMed ID: 30496606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic journey for individuals with fibrous dysplasia / McCune albright syndrome (FD/MAS).
    Song K; Shrestha R; Delaney H; Vijjhalwar R; Turner A; Sanchez M; Javaid MK
    Orphanet J Rare Dis; 2024 Feb; 19(1):50. PubMed ID: 38326833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choosing the Best Tissue and Technique to Detect Mosaicism in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS).
    Vado Y; Manero-Azua A; Pereda A; Perez de Nanclares G
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38255009
    [No Abstract]   [Full Text] [Related]  

  • 11. Denosumab use in bone fibrous dysplasia refractory to bisphosphonate: A retrospective multicentric study.
    Trojani MC; Gensburger D; Bagouet F; Cortet B; Couture G; Marcelli C; Mehsen Cetre N; Breuil V; Chapurlat R
    Bone; 2023 Sep; 174():116819. PubMed ID: 37301527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyostotic Fibrous Dysplasia With and Without McCune-Albright Syndrome-Clinical Features in a Nordic Pediatric Cohort.
    Utriainen P; Valta H; Björnsdottir S; Mäkitie O; Horemuzova E
    Front Endocrinol (Lausanne); 2018; 9():96. PubMed ID: 29599748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Risk of Breast Cancer at a Young Age in Women with Fibrous Dysplasia.
    Majoor BC; Boyce AM; Bovée JV; Smit VT; Collins MT; Cleton-Jansen AM; Dekkers OM; Hamdy NA; Dijkstra PS; Appelman-Dijkstra NM
    J Bone Miner Res; 2018 Jan; 33(1):84-90. PubMed ID: 28856726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium.
    Javaid MK; Boyce A; Appelman-Dijkstra N; Ong J; Defabianis P; Offiah A; Arundel P; Shaw N; Pos VD; Underhil A; Portero D; Heral L; Heegaard AM; Masi L; Monsell F; Stanton R; Dijkstra PDS; Brandi ML; Chapurlat R; Hamdy NAT; Collins MT
    Orphanet J Rare Dis; 2019 Jun; 14(1):139. PubMed ID: 31196103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia.
    Lietman SA; Ding C; Levine MA
    J Bone Joint Surg Am; 2005 Nov; 87(11):2489-94. PubMed ID: 16264125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and endocrine characteristics and genetic analysis of Korean children with McCune-Albright syndrome: a retrospective cohort study.
    Cho EK; Kim J; Yang A; Ki CS; Lee JE; Cho SY; Jin DK
    Orphanet J Rare Dis; 2016 Aug; 11(1):113. PubMed ID: 27506760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
    Meier ME; Clerkx SN; Winter EM; Pereira AM; van de Ven AC; van de Sande MAJ; Appelman-Dijkstra NM
    J Bone Miner Res; 2021 Sep; 36(9):1729-1738. PubMed ID: 34076303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological Interventions Targeting Pain in Fibrous Dysplasia/McCune-Albright Syndrome.
    Tucker-Bartley A; Selen DJ; Golden E; van Gool R; Ebb D; Mannstadt M; Upadhyay J
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone.
    Bianco P; Riminucci M; Majolagbe A; Kuznetsov SA; Collins MT; Mankani MH; Corsi A; Bone HG; Wientroub S; Spiegel AM; Fisher LW; Robey PG
    J Bone Miner Res; 2000 Jan; 15(1):120-8. PubMed ID: 10646121
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.